Culbertson T P, Sanchez J P, Gambino L, Sesnie J A
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.
J Med Chem. 1990 Aug;33(8):2270-5. doi: 10.1021/jm00170a035.
A series of fluoroquinolone antibacterials having the 7-position (10-position of pyridobenzoxazines) substituted with 2,7-diazaspiro[4.4]nonane (4b), 1,7-diazaspiro[4.4]nonane (5a), or 2,8-diazaspiro[5.5]undecane (6b) was prepared, and their biological activities were compared with piperazine and pyrrolidine substituted analogues. Most exhibited potent Gram-positive and Gram-negative activity, especially when side chain 4b was N-alkylated.
制备了一系列7位(吡啶并苯并恶嗪的10位)被2,7-二氮杂螺[4.4]壬烷(4b)、1,7-二氮杂螺[4.4]壬烷(5a)或2,8-二氮杂螺[5.5]十一烷(6b)取代的氟喹诺酮类抗菌剂,并将它们的生物活性与哌嗪和吡咯烷取代的类似物进行了比较。大多数表现出强效的革兰氏阳性和革兰氏阴性活性,尤其是当侧链4b被N-烷基化时。